Piyasa açık· · USD · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Nutex Health has become a high profile healthcare stock after a very large 3 year return, and the question now is whether that market price lines up with what the business is earning. With the move influenced by both operational progress and fresh risks, the key issue for anyone looking at Nutex Health is how much of its earnings power is already reflected in the current valuation. Over the past 3 years Nutex Health has delivered a very large share price gain, which puts extra pressure on...
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
Nutex Health (NUTX) just secured approval to dual-list its common stock on Nasdaq Texas, with trading expected to begin around September 23, 2026. This move may broaden liquidity and investor access. Recent trading has been choppy for Nutex Health, with the share price slipping 3.33% over the last day and 5.81% across the past week, even after a 30 day share price return of 7.32% and a 90 day gain of 21.31%, which leaves momentum still positive overall. Look beyond Nutex Health and review how...
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.